Cochlear Limited (OTC:CHEOY) Filings

Cochlear Limited

Filings

FilingDateTypeFiled with
Appendix 3Y - Michael del PradoNov 17, 2026Other filingsASX
Appendix 3Y - Diggory HowittNov 17, 2026Other filingsASX
Notification regarding unquoted securities - COHNov 17, 2026Other filingsASX
CMD details, CNA leader change & FY27 guidance reaffirmedNov 12, 2026GuidanceASX
2026 AGM ResultsOct 25, 2026Other filingsASX
2026 AGM Chair and CEO & President AddressesOct 25, 2026Other filingsASX
Ceasing to be a substantial holderOct 22, 2026Ownership change noticeASX
Notification of cessation of securities - COHOct 13, 2026FinancingASX
Notification regarding unquoted securities - COHOct 13, 2026Other filingsASX
Notification regarding unquoted securities - COHOct 13, 2026Other filingsASX
Ceasing to be a substantial holderOct 11, 2026Ownership change noticeASX
Change in substantial holdingOct 5, 2026Ownership change noticeASX
Defence of Class Action ProceedingsSep 28, 2026Legal or regulatory actionASX
Cochlear to host Capital Markets DaySep 24, 2026Other filingsASX
Notification regarding unquoted securities - COHSep 23, 2026Other filingsASX
Update - Dividend/Distribution - COHSep 22, 2026DividendASX
Notice of Annual General Meeting & Proxy/Voting FormSep 22, 2026Meeting noticeASX
Appointment of Prof. Ian Meredith to the Cochlear BoardSep 17, 2026Other filingsASX
Change in substantial holdingSep 17, 2026Ownership change noticeASX
Change in substantial holdingSep 6, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 6, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 4, 2026Ownership change noticeASX
S&P DJI Announces September 2026 Quarterly RebalanceSep 4, 2026Other filingsASX
Ceasing to be a substantial holderSep 4, 2026Ownership change noticeASX
Change in substantial holdingSep 3, 2026Ownership change noticeASX
Becoming a substantial holderSep 3, 2026Ownership change noticeASX
Appendix 3Y - Richard FreudensteinSep 2, 2026Other filingsASX
Becoming a substantial holderSep 2, 2026Ownership change noticeASX
Change in substantial holdingSep 2, 2026Ownership change noticeASX
Change in substantial holdingSep 1, 2026Ownership change noticeASX
Ceasing to be a substantial holderAug 28, 2026Ownership change noticeASX
Update - Notification of buy-back - COHAug 27, 2026Treasury share statusASX
Becoming a substantial holderAug 27, 2026Ownership change noticeASX
Appendix 3Y - Michael del PradoAug 26, 2026Other filingsASX
Appendix 3Y - Caroline ClarkeAug 26, 2026Other filingsASX
Change in substantial holdingAug 26, 2026Ownership change noticeASX
Change in substantial holdingAug 26, 2026Ownership change noticeASX
Appendix 3Y - Michael DaniellAug 24, 2026Other filingsASX
Appendix 3Y - Alison DeansAug 24, 2026Other filingsASX
Appendix 3Y - Christine McLoughlinAug 24, 2026Other filingsASX
Appendix 3Y - Karen PenroseAug 24, 2026Other filingsASX
Appendix 3Y - Diggory HowittAug 24, 2026Other filingsASX
Notification of cessation of securities - COHAug 24, 2026FinancingASX
FY26 Result - PresentationAug 17, 2026ResultsASX
Appendix 4GAug 17, 2026Other filingsASX
FY26 Result - ASX & Media ReleaseAug 17, 2026ResultsASX
2026 Tax Contribution ReportAug 17, 2026ESG reportASX
Dividend/Distribution - COHAug 17, 2026DividendASX
Annual ReportAug 17, 2026Annual reportASX
Appendix 4EAug 17, 2026ResultsASX
Date of AGM and closing date for director nominationsAug 16, 2026Meeting noticeASX
Change in substantial holdingAug 14, 2026Ownership change noticeASX
Change in substantial holdingAug 13, 2026Ownership change noticeASX
Becoming a substantial holderAug 12, 2026Ownership change noticeASX
Ceasing to be a substantial holderAug 6, 2026Ownership change noticeASX
Becoming a substantial holderAug 4, 2026Ownership change noticeASX
Notice of FY26 result analyst and media briefingJul 28, 2026Other filingsASX
Becoming a substantial holderJul 27, 2026Ownership change noticeASX
Trading update and reduction to FY26 earnings guidanceApr 21, 2026GuidanceASX
HY26 Result - Presentation SlidesFeb 12, 2026ResultsASX
HY26 Result - ASX & Media ReleaseFeb 12, 2026Other filingsASX
Appendix 4D and Half Year Financial ReportFeb 12, 2026Interim reportASX
2025 AGM Chair and CEO & President AddressesOct 22, 2025Other filingsASX
Update - Notification of buy-back - COHAug 14, 2025Treasury share statusASX
FY25 Result - ASX & Media ReleaseAug 14, 2025ResultsASX
FY25 Result - PresentationAug 14, 2025ResultsASX
Appendix 4EAug 14, 2025ResultsASX
Cochlear provides update to FY25 earnings guidanceJun 11, 2025GuidanceASX
Cochlear statement on US tariff announcementApr 8, 2025Other filingsASX
Cochlear awaits clarification on application of US tariffApr 2, 2025Explanation requestASX
HY25 Result - ASX & Media ReleaseFeb 13, 2025Other filingsASX
HY25 Result - Presentation SlidesFeb 13, 2025Other filingsASX
2024 AGM Chair and CEO & President AddressesOct 24, 2024Other filingsASX
FY24 Result - PresentationAug 14, 2024ResultsASX
FY24 Result - ASX & Media ReleaseAug 14, 2024ResultsASX
Cochlear acquires Demant cochlear implant businessMay 21, 2024Acquisition or disposalASX
HY24 Result - Presentation SlidesFeb 18, 2024Other filingsASX
HY24 Result - ASX & Media ReleaseFeb 18, 2024ResultsASX
Cochlear Upgrades FY24 Earnings GuidanceFeb 7, 2024GuidanceASX
2023 AGM Chair and CEO & President AddressesOct 16, 2023Other filingsASX
FY23 Result - PresentationAug 14, 2023Other filingsASX
FY23 Result - ASX & Media ReleaseAug 14, 2023Other filingsASX
Oticon Medical Acquisition - UK CMA Final Report & UpdateJun 22, 2023Acquisition or disposalASX
Provisional findings from the UK CMAApr 20, 2023Other filingsASX
HY23 Result - Presentation SlidesFeb 14, 2023Other filingsASX
HY23 Result - ASX & Media ReleaseFeb 14, 2023Other filingsASX
Oticon Medical acquisition - UK CMA decisionDec 6, 2022Acquisition or disposalASX
Acquisition of Oticon Medical-ACCC StatementNov 30, 2022Acquisition or disposalASX
2022 AGM Chair and CEO & President AddressesOct 17, 2022Other filingsASX
FY22 Result PresentationAug 18, 2022Other filingsASX
FY22 Result - ASX & Media ReleaseAug 18, 2022Other filingsASX
Cochlear agrees to acquire Oticon MedicalApr 27, 2022Acquisition or disposalASX
Half Year Results PresentationFeb 21, 2022Interim reportASX
Half Year Results AnnouncementFeb 21, 2022Interim reportASX
FY21 Result - ASX & Media ReleaseAug 19, 2021Other filingsASX
Half Yearly Report and AccountsFeb 18, 2021Interim reportASX
COH HY21 Result ASX & Media ReleaseFeb 18, 2021Other filingsASX
2020 AGM - Chairman and CEO & Presidents addressOct 19, 2020Other filingsASX
First quarter trading updateOct 19, 2020Other filingsASX
FY20 result - ASX & media releaseAug 17, 2020Other filingsASX
Settlement in US Patent Infringement CaseAug 17, 2020Other filingsASX
Confirmation of COVID-19 pandemic impact on tradingMay 10, 2020Other filingsASX
Cochlear Completes Share Purchase PlanApr 28, 2020FinancingASX
Cochlear Share Purchase Plan Offer OpenMar 31, 2020FinancingASX
Successful completion of A$880M Institutional PlacementMar 25, 2020FinancingASX
Investor PresentationMar 24, 2020Other filingsASX
Cochlear Limited announces capital raising to enhance liquidMar 24, 2020FinancingASX
Trading HaltMar 24, 2020Trading halt or suspensionASX
Adverse appeal decision in the US patent infringement caseMar 16, 2020Other filingsASX
Cochlear withdraws FY20 earnings guidance due to coronavirusMar 15, 2020GuidanceASX
HY20 Result Presentation SlidesFeb 17, 2020Other filingsASX
HY20 Result ASX & Media ReleaseFeb 17, 2020Other filingsASX
Cochlear reduces earnings guidance due to coronavirusFeb 10, 2020GuidanceASX
2019 Chairmans AGM Address to ShareholdersOct 21, 2019Other filingsASX
FY19 Results ASX & Media ReleaseAug 15, 2019Other filingsASX
COH - Profile Plus FDA ApprovalJun 16, 2019Other filingsASX
Cochlear announces launch of Nucleus Profile Plus implantApr 15, 2019Other filingsASX
COH Half Year Results Analyst - 19.02.2019Feb 18, 2019Interim reportASX
COH Half Year Results Media Release - 19.02.2019Feb 18, 2019Interim reportASX
COH - Ruling in USA Patent Infringement CaseNov 4, 2018Other filingsASX
2018 Chairmans AGM Address to ShareholdersOct 15, 2018Other filingsASX
Next phase development - totally implantable cochlear deviceOct 9, 2018Other filingsASX
COH FY18 Result AnnouncementAug 13, 2018Other filingsASX
Full Year Statutory Accounts - COH Appendix 4EAug 13, 2018Annual reportASX
COH announces release of Nucleus Smart App for AndroidJun 22, 2018Other filingsASX
COH Half Year Results Analyst PresentationFeb 12, 2018Interim reportASX
COH Half Year Results Media Release 13.02.2018Feb 12, 2018Interim reportASX
Half Year AccountsFeb 12, 2018Interim reportASX
COH CEO Transition and Related Board ChangesNov 13, 2017Other filingsASX
2017 Chairmans AGM Address to ShareholdersOct 16, 2017Other filingsASX
COH FY17 Result AnnouncementAug 16, 2017Other filingsASX
COCHLEAR TO EXPAND GLOBAL CAPACITYJul 13, 2017Other filingsASX
Cochlear acquires audiology practice management softwareMay 10, 2017Acquisition or disposalASX
COH Half Year Results Media ReleaseFeb 13, 2017Interim reportASX
Decision in US Patent Infringement CaseNov 17, 2016Other filingsASX
2016 Chairmans AGM Address to ShareholdersOct 17, 2016Other filingsASX
COH FY16 Result AnnouncementAug 8, 2016Other filingsASX
COH Clinic Update LetterMar 30, 2016Other filingsASX
Settlement Agreement with the DOJ and OIGMar 30, 2016Other filingsASX
Response to ASX Price QueryMar 30, 2016Explanation requestASX
COH Half Year Report as at 31 December 2009 09.02.10Mar 30, 2016Interim reportASX
Half Year Report and AccountsMar 30, 2016Interim reportASX
COH - F10 Preliminary Final Report - Appendix 4EMar 30, 2016ResultsASX
18/10/11 Chairman`s AGM Address to ShareholdersMar 30, 2016Other filingsASX
Preliminary Final Report Appendix 4EMar 30, 2016ResultsASX
Half Year Report & AccountsFeb 11, 2016Interim reportASX
Full Year Statutory Accounts and Annual ReportFeb 11, 2016Annual reportASX
COH Chris Smith Announced as Incoming CEO of CochlearFeb 11, 2016Other filingsASX
Judgment in United States Patent Infringement LawsuitFeb 11, 2016Other filingsASX
DECISION IN US PATENT INFRINGEMENT CASEFeb 11, 2016Other filingsASX
COH Full Year Results Media Release 05.08.14Feb 10, 2016ResultsASX
Preliminary Final Report and Full Year Statutory AccountsFeb 10, 2016Annual reportASX
COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROPFeb 10, 2016Other filingsASX
FDA approves Cochlear Nucleus Hybrid for sale in USAFeb 10, 2016Other filingsASX
COH Jury Trial Verdict on USA Patent Infringement CaseFeb 10, 2016Other filingsASX
Hybrid Hearing Device UpdateFeb 10, 2016Other filingsASX
15/10/13 Chairmans AGM Address to ShareholdersFeb 10, 2016Other filingsASX
Full Year Statutory AccountsFeb 10, 2016Annual reportASX
Cochlear Limited Market UpdateFeb 10, 2016Other filingsASX
COH Update on Nucleus CI500 series implant recallFeb 10, 2016Other filingsASX
Appendix 4E and Full Year Statutory AccountsFeb 10, 2016Annual reportASX
Cochlear Voluntary RecallFeb 10, 2016Other filingsASX